Amr Alkasir

Dr. Amr Alkasir


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
KMKareem Mohamed
Kareem Mohamed
Mohamed N. ElshabrawiMohamed N. Elshabrawi
Mohamed N. Elshabrawi
AAAmr Alkasir
Amr Alkasir
AHAhmed Hanfy
Ahmed Hanfy
MSMohammed Saifuddin
Mohammed Saifuddin
MAMagdy Abdelhamid
Magdy Abdelhamid
Inherited arrhythmia syndromes have traditionally been classified as either primary electrical disorders or structural cardiomyopathies, a framework that increasingly fails to capture the tissue-level abnormalities identified across this spectrum. Cardiac magnetic resonance (CMR) imaging has emerged as a pivotal tool in reframing this paradigm by combining precise ventricular phenotyping with myocardial tissue characterization. In classic channelopathies such as long QT syndrome and catecholaminergic polymorphic ventricular tachycardia, CMR remains primarily exclusionary, while in structural diseases such as arrhythmogenic and hypertrophic cardiomyopathy, it directly identifies the arrhythmogenic substrate through late gadolinium enhancement and parametric mapping. Brugada syndrome occupies an intermediate position, with emerging evidence of subtle right ventricular outflow tract abnormalities challenging its classification as a purely electrical disorder. This review examines the disease-specific diagnostic yield of CMR, its expanding role in risk stratification and implantable cardioverter-defibrillator decision-making, and future directions including artificial intelligence-driven analysis and genotype-phenotype correlation.